| scholarly article | Q13442814 |
| P2093 | author name string | Raghavan D | |
| P2860 | cites work | The chemotherapy of urologic cancer | Q35058173 |
| Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity | Q35981386 | ||
| Biology and management of bladder cancer | Q37911018 | ||
| Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contra-indication | Q38595723 | ||
| Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer | Q39628781 | ||
| Publication bias: the case for an international registry of clinical trials | Q39795619 | ||
| Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium | Q40785644 | ||
| Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse | Q43419722 | ||
| The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study | Q46536486 | ||
| A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract | Q46565121 | ||
| M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium | Q48104435 | ||
| Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study | Q49261578 | ||
| Cis-diamminedichloroplatinum (DDP) as initial treatment of invasive bladder cancer. | Q51842811 | ||
| Meta-analyses of randomized controlled trials. | Q52603476 | ||
| Intra-arterial chemotherapy of infiltrative bladder carcinoma. | Q53963656 | ||
| Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer? | Q54320248 | ||
| Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder? | Q68251357 | ||
| The role of radiation therapy and chemotherapy in the treatment of invasive carcinoma of the urinary bladder | Q68477858 | ||
| Response criteria phase II/phase III invasive bladder cancer | Q68930990 | ||
| Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial | Q68945079 | ||
| Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis | Q69387119 | ||
| Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern | Q69401186 | ||
| Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion | Q69716742 | ||
| Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen | Q69776041 | ||
| Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract | Q69886661 | ||
| Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer | Q69943436 | ||
| Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report | Q70243006 | ||
| A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study | Q70268069 | ||
| Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response | Q70502833 | ||
| Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer | Q71363037 | ||
| Chemotherapy of human solid tumors with 5-fluorouracil | Q79108523 | ||
| Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium | Q93606365 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| bladder cancer | Q504775 | ||
| P304 | page(s) | 337-340 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'? | |
| P478 | volume | 62 |
| Q33701109 | Evaluating prognostic factors: implications for measurement of health care outcome |
| Q54139918 | Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response. |
| Q24236721 | Neoadjuvant cisplatin for advanced bladder cancer |
| Q33909835 | Neoadjuvant cisplatin for advanced bladder cancer. |
Search more.